Is Aspirin Still the Cornerstone of Antiplatelet Therapy in Patients With Coronary Artery Disease? An Historical and Practical Narrative Review

Is Aspirin Still the Cornerstone of Antiplatelet Therapy in Patients With Coronary Artery Disease? An Historical and Practical Narrative Review

Aspirin is an irreversible and non-selective inhibitor of cyclo-oxygenase. It represents the cornerstone of antiplatelet therapy and is used in secondary prevention of cardiovascular disease. Disagreement over the optimal maintenance dosage still exists; in America and Europe the most used doses of...

Full description

Bibliographic Details
Main Authors: Carol Gravinese, Matteo Bianco, Enrico Cerrato, Paola Destefanis, Alessia Luciano, Alessandro Bernardi, Simone Bellucca, Ferdinando Varbella, Fiorenzo Gaita, Roberto Pozzi
Format: Article
Language:English
Published: Baqiyatallah University of Medical Sciences 2017-08-01
Series:Hospital Practices and Research
Subjects:
Coronary Artery Disease/Therapy
Drug Therapy
Combination Drug-Eluting Stents
Platelet Aggregation Inhibitors/Administration and Dosage
Platelet Aggregation Inhibitors/Adverse Effects
Percutaneous Coronary Intervention
Online Access:http://www.jhpr.ir/article_49556_72a3e11c4858402b6b11c40de8732806.pdf

Internet

http://www.jhpr.ir/article_49556_72a3e11c4858402b6b11c40de8732806.pdf

Similar Items